Morgan Stanley raises target for Amplifon stock to EUR 14.96
Published on 10/09/2026 at 13:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Morgan Stanley raised its Amplifon target to EUR 14.96 from EUR 14.90 on October 9, 2026.
- Amplifon's first-half 2026 revenue reached EUR 1.19 billion, up 1.30 percent at constant exchange rates.
- Amplifon stock was at EUR 12.25 at Lang & Schwarz, plus 1.24 percent versus the prior close.
- Third-quarter results and a shareholder meeting are scheduled for October 29, 2026.
Amplifon (ISIN IT0004056880) stock was trading at EUR 12.25 at Lang & Schwarz on October 9, 2026 at 1:36 p.m. CEST, up 1.24 percent versus the prior close of EUR 12.10. On October 9, 2026, Teleborsa reported that Morgan Stanley retained its Overweight rating and raised its target from EUR 14.90 to EUR 14.96. The move gives the latest analyst view a clear numerical anchor.
Three milestones reshape the story
On March 16, 2026, Amplifon announced an agreement to acquire GN Hearing for an enterprise value of EUR 2.30 billion, according to Rankia. The transaction included EUR 1.69 billion in cash and 56.00 million new Amplifon shares.
On May 22, 2026, the same Rankia report said Amplifon placed 45.30 million new shares at EUR 10.00, raising EUR 453.00 million gross. On October 9, 2026, Morgan Stanley's target moved to EUR 14.96 from EUR 14.90, the most recent dated milestone.
What does the target change mean?
The new Morgan Stanley target lies 22.12 percent above the Lang & Schwarz price of EUR 12.25, calculated in euros. That gap is larger than the 0.06 euro target increase itself, so the central question is valuation rather than the size of the revision.
Operationally, Amplifon's first-half 2026 revenue reached EUR 1.19 billion, up 1.30 percent at constant exchange rates, while adjusted EBITDA rose 3.60 percent to EUR 298.00 million, according to Rankia. The adjusted EBITDA margin reached 25.10 percent, an increase of 70 basis points, giving the target revision an operating-performance reference.
Two October 29 events matter
Amplifon's third-quarter 2026 results are scheduled for October 29, 2026, according to Rankia. The shareholder meeting on the same date covers matters linked to the GN Hearing transaction, as stated in Amplifon Corporate on September 29, 2026.
Amplifon stock stays below its yearly high
Amplifon stock was trading at EUR 12.25 at Lang & Schwarz on October 9, 2026 at 1:36 p.m. CEST, with a prior close of EUR 12.10 on October 8, 2026. The primary listing is on Euronext Milan, where the finance calendar and acquisition timetable leave the October 29 results as the next major company-specific test.
The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.
Amplifon stock facts
- Company: Amplifon S.p.A.
- ISIN: IT0004056880
- Ticker: AMP
- Primary exchange: Euronext Milan
- Price Lang & Schwarz (as of October 9, 2026, 1:36 p.m. CEST): EUR 12.25
- Change versus prior close: plus 1.24 percent
- Prior close Lang & Schwarz (October 8, 2026): EUR 12.10
- Market capitalization: EUR 2.7 billion (as of October 9, 2026)
- 52-week range: EUR 7.84-EUR 15.84 (as of October 9, 2026)
- Sector / Industry: Health Care / Medical Equipment, Supplies and Distribution
- Index membership: FTSE MIB
- Next earnings date: October 29, 2026
Market context: Market report FTSE MIB.
